Key Takeaways PAHC's Q2 outlook calls for $357M in revenues, up 15.4% year over year, with EPS seen at 69 cents.Phibro's Animal Health segment is expected to gain from MFA strength, nutrition growth and vaccines demand.PAHC may see mixed trends, with weaker Mineral Nutrition offset by stronger Performance Products sales.Phibro Animal Health Corp. (PAHC) is expected to release second-quarter fiscal 2026 results soon.In the last reported quarter, the company posted adjusted earnings per share (EPS) of 73 cent ...